Nuwellis Inc. Stock
Nuwellis Inc. Stock
The community is currently still undecided about Nuwellis Inc. with 2 Buy predictions and 0 Sell predictions.
Based on the current price of 0.11 € the target price of 15 € shows a potential of 13057.89% for Nuwellis Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Nuwellis Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Nuwellis Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nuwellis Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nuwellis Inc. | - | - | - | - | - | - | - |
| MicroVision Inc | 3.320% | 17.248% | 22.338% | -52.266% | -59.382% | -90.611% | 93.074% |
| Fonar Corp. New | -1.890% | 6.122% | 2.632% | 6.122% | -11.864% | 9.859% | -23.604% |
| Allscripts Healthcare | 6.670% | 0.000% | 0.000% | -32.203% | -13.514% | -29.825% | -14.411% |
Comments
Nuwellis, Inc. (NASDAQ: NUWE) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $17.00 price target on the stock.
Show more
Ratings data for NUWE provided by MarketBeat
Nuwellis, Inc. (NASDAQ: NUWE) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $17.00 price target on the stock.
Show more
Ratings data for NUWE provided by MarketBeat